27898058|t|CCL5/RANTES contributes to hypothalamic insulin signaling for systemic insulin responsiveness through CCR5.
27898058|a|Many neurodegenerative diseases are accompanied by metabolic disorders. CCL5/RANTES, and its receptor CCR5 are known to contribute to neuronal function as well as to metabolic disorders such as type 2 diabetes mellitus, obesity, atherosclerosis and metabolic changes after HIV infection. Herein, we found that the lack of CCR5 or CCL5 in mice impaired regulation of energy metabolism in hypothalamus. Immunostaining and co-immunoprecipitation revealed the specific expression of CCR5, associated with insulin receptors, in the hypothalamic arcuate nucleus (ARC). Both ex vivo stimulation and in vitro tissue culture studies demonstrated that the activation of insulin, and PI3K-Akt pathways were impaired in CCR5 and CCL5 deficient hypothalamus. The inhibitory phosphorylation of insulin response substrate-1 at Ser302 (IRS-1S302) but not IRS-2, by insulin was markedly increased in CCR5 and CCL5 deficient animals. Elevating CCR5/CCL5 activity induced GLUT4 membrane translocation and reduced phospho-IRS-1S302 through AMPKalpha-S6 Kinase. Blocking CCR5 using the antagonist, MetCCL5, abolished the de-phosphorylation of IRS-1S302 and insulin signal activation. In addition, intracerebroventricular delivery of MetCCL5 interrupted hypothalamic insulin signaling and elicited peripheral insulin responsiveness and glucose intolerance. Taken together, our data suggest that CCR5 regulates insulin signaling in hypothalamus which contributes to systemic insulin sensitivity and glucose metabolism.
27898058	0	4	CCL5	Gene	20304
27898058	5	11	RANTES	Gene	20304
27898058	102	106	CCR5	Gene	12774
27898058	113	139	neurodegenerative diseases	Disease	MESH:D019636
27898058	159	178	metabolic disorders	Disease	MESH:D008659
27898058	180	184	CCL5	Gene	20304
27898058	185	191	RANTES	Gene	20304
27898058	210	214	CCR5	Gene	12774
27898058	274	293	metabolic disorders	Disease	MESH:D008659
27898058	302	326	type 2 diabetes mellitus	Disease	MESH:D003924
27898058	328	335	obesity	Disease	MESH:D009765
27898058	337	352	atherosclerosis	Disease	MESH:D050197
27898058	381	394	HIV infection	Disease	MESH:D015658
27898058	430	434	CCR5	Gene	12774
27898058	438	442	CCL5	Gene	20304
27898058	446	450	mice	Species	10090
27898058	587	591	CCR5	Gene	12774
27898058	786	789	Akt	Gene	11651
27898058	816	820	CCR5	Gene	12774
27898058	825	829	CCL5	Gene	20304
27898058	947	952	IRS-2	Gene	384783
27898058	991	995	CCR5	Gene	12774
27898058	1000	1004	CCL5	Gene	20304
27898058	1034	1038	CCR5	Gene	12774
27898058	1039	1043	CCL5	Gene	20304
27898058	1061	1066	GLUT4	Gene	20528
27898058	1158	1162	CCR5	Gene	12774
27898058	1185	1192	MetCCL5	Gene	20304
27898058	1320	1327	MetCCL5	Gene	20304
27898058	1422	1441	glucose intolerance	Disease	MESH:D018149
27898058	1481	1485	CCR5	Gene	12774
27898058	1584	1591	glucose	Chemical	MESH:D005947
27898058	Bind	12774	20304
27898058	Positive_Correlation	12774	20528
27898058	Association	MESH:D008659	12774
27898058	Association	MESH:D015658	20304
27898058	Association	MESH:D003924	12774
27898058	Positive_Correlation	MESH:D018149	20304
27898058	Positive_Correlation	11651	12774
27898058	Association	MESH:D009765	20304
27898058	Association	MESH:D005947	12774
27898058	Association	MESH:D008659	20304
27898058	Association	MESH:D050197	20304
27898058	Association	MESH:D009765	12774
27898058	Association	MESH:D050197	12774
27898058	Association	MESH:D003924	20304
27898058	Positive_Correlation	20304	20528
27898058	Association	MESH:D015658	12774

